Referências

1. Akagunduz O.O., Kamer S.A., Kececi B., Et al., The role of radiotherapy in local control of nonextremity ewing sarcomas, Tumori, 102, pp. 162-167, (2016)
2. Albergo J.I., Gaston C.L., Laitinen M., Et al., Ewing's sarcoma: Only patients with 100% of necrosis after chemotherapy should be classified as having a good response, The Bone & Joint Journal, 8, pp. 1138-1144, (2016)
3. Allan C.J., Soule E.H., Osteogenic sarcoma of the somatic soft tissues. Clinicopathologic study of 26 cases and review of literature, Cancer, 27, pp. 1121-1133, (1971)
4. Amanatullah D.F., Clark T.R., Lopez M.J., Borys D., Tamurian R.M., Giant cell tumor of bone, Orthopedics, 37, pp. 112-120, (2014)
5. Anderson M.E., Update on survival in osteosarcoma, The Orthopedic Clinics of North America, 47, pp. 283-292, (2016)
6. Andreou D., Ruppin S., Fehlberg S., Et al., Survival and prognostic factors in chondrosarcoma: Results in 115 patients with long-term follow-up, Acta Orthopaedica, 82, pp. 749-755, (2011)
7. Angelini A., Guerra G., Mavrogenis A.F., Et al., Clinical outcome of central conventional chondrosarcoma, Journal of Surgical Oncology, 106, pp. 929-937, (2012)
8. Angelini A., Ceci F., Castellucci P., Et al., The role of (18)F-FDG PET/CT in the detection of osteosarcoma recurrence, European Journal of Nuclear Medicine and Molecular Imaging, 44, pp. 1712-1720, (2017)
9. Annovazzi A., Anelli V., Zoccali C., Et al., (18)F-FDG PET/CT in the evaluation of cartilaginous bone neoplasms: The added value of tumor grading, Annals of Nuclear Medicine, 33, pp. 813-821, (2019)
10. Bacci G., Forni C., Longhi A., Et al., Local recurrence and local control of non-metastatic osteosarcoma of the extremities: A 27-year experience in a single institution, Journal of Surgical Oncology, 96, pp. 118-123, (2007)
11. Baldauf M.C., Orth M.F., Dallmayer M., Et al., Robust diagnosis of ewing sarcoma by immunohistochemical detection of super-enhancer-driven ewsr1-ets targets, Oncotarget, 9, (2017)
12. Cui F., Su M., Zhang H., Tian R., Humeral metastasis of sacrococcygeal chordoma detected by fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography: A case report, Radiology Case Reports, 13, pp. 449-452, (2018)
13. D'Amore T., Boyce B., Mesfin A., Chordoma of the mobile spine and sacrum: Clinical management and prognosis, Journal of Spine Surgery, 4, pp. 546-552, (2018)
14. Davis J.C., Daw N.C., Navid F., Et al., (18)F-FDG uptake during early adjuvant chemotherapy predicts histologic response in pediatric and young adult patients with osteosarcoma, Journal of Nuclear Medicine, 59, pp. 25-30, (2018)
15. Delaney T.F., Park L., Goldberg S.I., Et al., Radiotherapy for local control of osteosarcoma, International Journal of Radiation Oncology, Biology, Physics, 61, pp. 492-498, (2005)
16. Dhinsa B.S., Delisa M., Pollock R., Et al., Dedifferentiated chondrosarcoma demonstrating osteosarcomatous differentiation, Oncology Research and Treatment, 41, pp. 456-460, (2018)
17. Duchman K.R., Gao Y., Miller B.J., Prognostic factors for survival in patients with high-grade osteosarcoma using the surveillance, epidemiology, and end results (seer) program database, Cancer Epidemiology, 39, pp. 593-599, (2015)
18. Engellau J., Seeger L., Grimer R., Et al., Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone, World Journal of Surgical Oncology, 16, (2018)
19. Enneking W.F., Kagan A., “Skip” metastases in osteosarcoma, Cancer, 36, pp. 2192-2205, (1975)
20. Feldman F., Van Heertum R., Saxena C., Parisien M., 18FDG-PET applications for cartilage neoplasms, Skeletal Radiology, 34, pp. 367-374, (2005)
21. Franzius C., Sciuk J., Daldrup-Link H.E., Jurgens H., Schober O., FDG-PET for detection of osseous metastases from malignant primary bone tumours: Comparison with bone scintigraphy, European Journal of Nuclear Medicine, 27, pp. 1305-1311, (2000)
22. Mirabello L., Troisi R.J., Savage S.A., International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons, International Journal of Cancer, 125, pp. 229-234, (2009)
23. Ferguson J.L., Turner S.P., Bone cancer: Diagnosis and treatment principles, American Family Physician, 98, pp. 205-213, (2018)
24. Frezza A.M., Botta L., Trama A., Dei Tos A.P., Stacchiotti S., Chordoma: Update on disease, epidemiology, biology and medical therapies, Current Opinion in Oncology, 31, pp. 114-120, (2019)
25. Gao Z., Lu T., Song H., Et al., Prognostic factors and treatment options for patients with high-grade chondrosarcoma, Medical Science Monitor, 25, pp. 8952-8967, (2019)
26. Gaspar N., Rey A., Berard P.M., Et al., Risk adapted chemotherapy for localised ewing's sarcoma of bone: The french ew93 study, European Journal of Cancer, 48, pp. 1376-1385, (2012)
27. Gaston L.L., Di Bella C., Slavin J., Hicks R.J., Choong P.F., 18F-FDG PET response to neoadjuvant chemotherapy for ewing sarcoma and osteosarcoma are different, Skeletal Radiology, 40, pp. 1007-1015, (2011)
28. Ghafoor S., Hameed M.R., Tap W.D., Hwang S., Mesenchymal chondrosarcoma: Imaging features and clinical findings, Skeletal Radiology, 50, pp. 333-341, (2021)
29. Goto M., Miller R.W., Ishikawa Y., Sugano H., Excess of rare cancers in werner syndrome (adult progeria), Cancer Epidemiology, Biomarkers & Prevention, 5, pp. 239-246, (1996)
30. Grunewald T.G.P., Cidre-Aranaz F., Surdez D., Et al., Ewing sarcoma, Nature Reviews. Disease Primers, 4, (2018)
31. Harrison D.J., Parisi M.T., Shulkin B.L., The role of (18)F-FDG-PET/CT in pediatric sarcoma, Seminars in Nuclear Medicine, 47, pp. 229-241, (2017)
32. He J.P., Hao Y., Li M., Wang J., Guo F.J., Tumor-to-background ratio to predict response to chemotherapy of osteosarcoma better than standard uptake values, Orthopaedic Surgery, 6, pp. 145-153, (2014)
33. Mirabello L., Troisi R.J., Savage S.A., Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program, Cancer, 115, pp. 1531-1543, (2009)
34. Hindi N., Casali P.G., Morosi C., Et al., Imatinib in advanced chordoma: A retrospective case series analysis, European Journal of Cancer, 51, pp. 2609-2614, (2015)
35. Hiz M., Karaismailoglu B., Ulutas S., Et al., The effect of preoperative radiotherapy on local control and prognosis in high-grade non-metastatic intramedullary osteosarcoma of the extremities, Archives of Orthopaedic and Trauma Surgery, 141, pp. 1083-1089, (2020)
36. Hoshi M., Takada J., Oebisu N., Et al., Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT, Archives of Orthopaedic and Trauma Surgery, 132, pp. 1561-1568, (2012)
37. Hou S., Lin X., Wang S., Et al., Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology, Medicine (Baltimore), 97, (2018)
38. Huang T., Li F., Yan Z., Et al., Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of ewing sarcoma family of tumors: A meta-analysis of 23 studies, Medicine (Baltimore), 97, (2018)
39. Huvos A.G., Osteogenic sarcoma of bones and soft tissues in older persons, Cancer, 57, pp. 1142-1149, (1986)
40. Iagaru A., Chawla S., Menendez L., Conti P.S., 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas, Nuclear Medicine Communications, 27, (2006)
41. Jamet B., Carlier T., Campion L., Et al., Initial fdg-pet/ct predicts survival in adults ewing sarcoma family of tumors, Oncotarget, 8, pp. 77050-77060, (2017)
42. Jefree G.M., Price C.H.G., Sissons H.A., The metastatic patterns of osteosarcoma, British Journal of Cancer, 32, pp. 87-107, (1975)
43. Jeong W., Kim H.J., Biomarkers of chondrosarcoma, Journal of Clinical Pathology, 71, pp. 579-583, (2018)
44. Mirzaei L., Kaal S.E., Schreuder H.W., Bartels R.H., The neurological compromised spine due to ewing sarcoma. What first: Surgery or chemotherapy? Therapy, survival, and neurological outcome of 15 cases with primary ewing sarcoma of the vertebral column, Neurosurgery, 77, pp. 718-724, (2015)
45. Jesus-Garcia R., Osawa A., Filippi R.Z., Et al., Is pet-ct an accurate method for the differential diagnosis between chondroma and chondrosarcoma?, Springerplus, 5, (2016)
46. Jo I., Gould D., Schlicht S., Taubman K., Choong P., Diagnostic accuracy of functional imaging modalities for chondrosarcoma: A systematic review and meta-analysis, Journal of Bone Oncology, 19, (2019)
47. Kager L., Zoubek A., Potschger U., Et al., Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols, Journal of Clinical Oncology, 21, pp. 2011-2018, (2003)
48. Kasalak O., Glaudemans A., Overbosch J., Jutte P.C., Kwee T.C., Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in ewing sarcoma?, Skeletal Radiology, 47, pp. 363-367, (2018)
49. Kayani B., Hanna S.A., Sewell M.D., Et al., A review of the surgical management of sacral chordoma, European Journal of Surgical Oncology, 40, pp. 1412-1420, (2014)
50. Kishimoto R., Omatsu T., Hasegawa A., Et al., Imaging characteristics of metastatic chordoma, Japanese Journal of Radiology, 30, pp. 509-516, (2012)
51. Konieczkowski D.J., Delaney T.F., Yamada Y.J., Radiation strategies for spine chordoma: Proton beam, carbon ions, and stereotactic body radiation therapy, Neurosurgery Clinics of North America, 31, pp. 263-288, (2020)
52. Kubo T., Furuta T., Johan M.P., Ochi M., Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma
53. systematic review and meta-analysis, European Journal of Cancer, 58, pp. 104-111, (2016)
54. Kumar R., Kumar M., Malhotra K., Patel S., Primary osteosarcoma in the elderly revisited: Current concepts in diagnosis and treatment, Current Oncology Reports, 20, (2018)
55. Montgomery C., Couch C., Emory C.L., Nicholas R., Giant cell tumor of bone: Review of current literature, evaluation, and treatment options, The Journal of Knee Surgery, 32, pp. 331-336, (2019)
56. Laitinen M.K., Stevenson J.D., Parry M.C., Et al., The role of grade in local recurrence and the disease-specific survival in chondrosarcomas, The Bone & Joint Journal, 100-B, 5, (2018)
57. Leddy L.R., Holmes R.E., Chondrosarcoma of bone, Cancer Treatment and Research, 162, pp. 117-130, (2014)
58. Lee J.S.Y., Fetsch J.F., Wasdhal D.A., Lee B.P., Pritchard D.J., A review of 40 patients with extraskeletal osteosarcoma, Cancer, 76, pp. 2253-2259, (1995)
59. Lim H.J., Johnny Ong C.A., Tan J.W., Ching Teo M.C., Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review, Critical Reviews in Oncology/Hematology, 143, pp. 1-13, (2019)
60. Lin C.Y., Kao C.W., Liang J.A., Et al., Chordoma detected on F-18 FDG PET, Clinical Nuclear Medicine, 31, (2006)
61. Lindsey B.A., Markel J.E., Kleinerman E.S., Osteosarcoma overview, Rheumatology and Therapy, 4, pp. 25-43, (2017)
62. Liu F., Zhang Q., Zhou D., Dong J., Effectiveness of (18)F-FDG PET/CT in the diagnosis and staging of osteosarcoma: A meta-analysis of 26 studies, BMC Cancer, 19, (2019)
63. Macpherson R.E., Pratap S., Tyrrell H., Et al., Retrospective audit of 957 consecutive (18)F-FDG PET-CT scans compared to ct and mri in 493 patients with different histological subtypes of bone and soft tissue sarcoma, Clinical Sarcoma Research, 8, (2018)
64. Makis W., Alabed Y.Z., Nahal A., Novales-Diaz J.A., Hickeson M., Giant cell tumor pulmonary metastases mimic primary malignant pulmonary nodules on (18)F-FDG PET/CT, Nuclear Medicine and Molecular Imaging, 46, pp. 134-137, (2012)
65. Malone S., O'sullivan B., Catton C., Et al., Long-term follow-up of efficacy and safety of megavoltage radiotherapy in high-risk giant cell tumors of bone, International Journal of Radiation Oncology, Biology, Physics, 33, pp. 689-694, (1995)
66. Movahedinia S., Shooshtarizadeh T., Mostafavi H., Secondary malignant transformation of giant cell tumor of bone: Is it a fate?, Iranian Journal of Pathology, 14, pp. 165-174, (2019)
67. Mankin H.J., Chondrosarcomas of digits: Are they really malignant?, Cancer, 89, (1999)
68. Manoso M.W., Healey J.H., Boland P.J., Et al., De novo osteogenic sarcoma in patients older than forty: Benefit of multimodality therapy, Clinical Orthopaedics and Related Research, 438, pp. 110-115, (2005)
69. Mavrogenis A.F., Igoumenou V.G., Megaloikonomos P.D., Et al., Giant cell tumor of bone revisited, SICOT Journal, 3, (2017)
70. McCarter M.D., Lewis J.J., Antonescu C.R., Brennan M.F., Extraskeletal osteosarcoma: Analysis of outcome of a rare neoplasm, Sarcoma, 4, pp. 119-123, (2000)
71. McKinney A.M., Reichert P., Short J., Dhurairaj T., SantaCruz K., McKinney Z., Kieffer S., Metachronous, multicentric giant cell tumor of the sphenoid bone with histologic, CT, MR imaging, and positron-emission tomography/ct correlation, American Journal of Neuroradiology, 27, (2006)
72. McMaster M.L., Goldstein A.M., Bromley C.M., Ishibe N., Parry D.M., Chordoma: Incidence and survival patterns in the United States, 1973 ± 1995, Cancer Causes and Control, 12, (2001)
73. Meyers P.A., Gorlick R., Heller G., Et al., Intensification of preoperative chemotherapy for osteogenic sarcoma: Results of the memorial sloan-kettering (t12) protocol, Journal of Clinical Oncology, 16, pp. 2452-2458, (1998)
74. Miller I.J., Blank A., Yin S.M., Et al., A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases, Diagnostic Pathology, 1-7, (2010)
75. Muheremu A., Niu X., Pulmonary metastasis of giant cell tumor of bones, World Journal of Surgical Oncology, 12, (2014)
76. Muheremu A., Ma Y., Huang Z., Et al., Diagnosing giant cell tumor of the bone using positron emission tomography/computed tomography: A retrospective study of 20 patients from a single center, Oncology Letters, 14, pp. 1985-1988, (2017)
77. Nanni C., Gasbarrini A., Cappelli A., Et al., FDG PET/CT for bone and soft-tissue biopsy, European Journal of Nuclear Medicine and Molecular Imaging, 42, pp. 1333-1334, (2015)
78. Nazeri E., Gouran Savadkoohi M., Majidzadeh A.K., Esmaeili R., Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets, Critical Reviews in Oncology/Hematology, 131, pp. 102-109, (2018)
79. O'sullivan P.J., Rohren E.M., Madewell J.E., Positron emission tomography-CT imaging in guiding musculoskeletal biopsy, Radiologic Clinics of North America, 46, pp. 475-486, (2008)
80. Bane B.L., Evans H.L., Ro J.Y., Et al., Extraskeletal osteosarcoma: A clinicopathologic review of 26 cases, Cancer, 65, pp. 2762-2770, (1990)
81. Ottaviani G., Jaffe N., The epidemiology of osteosarcoma, Cancer Treatment and Research, 152, pp. 3-13, (2009)
82. Palmerini E., Picci P., Reichardt P., Downey G., Malignancy in giant cell tumor of bone: A review of the literature, Technology in Cancer Research & Treatment, 18, (2019)
83. Parghane R.V., Basu S., Dual-time point (18)F-FDG-PET and PET/CT for differentiating benign from malignant musculoskeletal lesions: Opportunities and limitations, Seminars in Nuclear Medicine, 47, pp. 373-391, (2017)
84. Park S.-A., Kim H.S., F-18 FDG PET/CT evaluation of sacrococcygeal chordoma, Clinical Nuclear Medicine, 33, (2008)
85. Park H.J., Kwon S.Y., Cho S.-G., Et al., Giant cell tumor with secondary aneurysmal bone cyst shows heterogeneous metabolic pattern on (18)F-FDG PET/CT: A case report, Nuclear Medicine and Molecular Imaging, 50, pp. 348-352, (2016)
86. Porter D.E., Holden S.T., Steel C.M., Et al., A significant proportion of patients with osteosarcoma may belong to li-fraumeni cancer families, Journal of Bone and Joint Surgery, 74, pp. 883-886, (1992)
87. Raskin K.A., Schwab J.H., Mankin H.J., Springfield D.S., Hornicek F.J., Giant cell tumor of bone, The Journal of the American Academy of Orthopaedic Surgeons, 21, pp. 118-126, (2013)
88. Rosenberg A.E., Bone sarcoma pathology: Diagnostic approach for optimal therapy, American Society of Clinical Oncology Educational Book, 37, pp. 794-798, (2017)
89. Ruggiero A., Lanni V., Librizzi A., Maurizi P., Attina G., Riccardi R., Diagnostic accuracy of 18F-FDG PET/CT in the staging and assessment of response to chemotherapy in children with ewing sarcoma, Journal of Pediatric Hematology/Oncology, 40, (2018)
90. Ruka W., Rutkowski P., Morysinski T., Et al., The megavoltage radiation therapy in treatment of patients with advanced or difficult giant cell tumors of bone, International Journal of Radiation Oncology, Biology, Physics, 78, pp. 494-498, (2010)
91. Bastiaannet E., Groen H., Jager P.L., Et al., The value of fdg-pet in the detection, grading and response to therapy of soft tissue and bone sarcomas
92. Saeter G., Hoie J., Stenwig A.E., Et al., Systemic relapse os patients with osteogenic sarcoma. Prognostic factors for long term survival, Cancer, 75, pp. 1084-1093, (1995)
93. Sahyouni R., Goshtasbi K., Mahmoodi A., Chen J.W., A historical recount of chordoma, Journal of Neurosurgery. Spine, 28, pp. 422-428, (2018)
94. Salem U., Amini B., Chuang H.H., Et al., (18)F-FDG PET/CT as an indicator of survival in ewing sarcoma of bone, Journal of Cancer, 8, pp. 2892-2898, (2017)
95. Schuetze S.M., Utility of positron emission tomography in sarcomas, Current Opinion in Oncology, 18, (2006)
96. Schulte M., Brecht-Krauss D., Heymer B., Et al., Grading of tumors and tumorlike lesions of bone: Evaluation by FDG PET, Journal of Nuclear Medicine, 41, pp. 1695-1701, (2000)
97. Scott M.C., Sarver A.L., Tomiyasu H., Et al., Aberrant retinoblastoma (rb)-e2f transcriptional regulation defines molecular phenotypes of osteosarcoma, The Journal of Biological Chemistry, 290, pp. 28070-28083, (2015)
98. Sheikhbahaei S., Marcus C., Hafezi-Nejad N., Taghipour M., Subramaniam R.M., Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas, PET Clinics, 10, pp. 375-393, (2015)
99. Shin D.S., Shon O.J., Han D.S., Et al., The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors, Annals of Nuclear Medicine, 22, pp. 603-609, (2008)
100. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones, The Journal of Bone and Joint Surgery. American Volume, 89, pp. 2113-2123, (2007)
101. Skubitz K.M., Giant cell tumor of bone: Current treatment options, Current Treatment Options in Oncology, 15, pp. 507-518, (2014)
102. a systematic review and meta-analysis, Cancer Treatment Reviews, 30, pp. 83-101, (2004)
103. Sobic Saranovic D.P., Nikitovic M., Saponjski J., Et al., Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and pnet, European Journal of Radiology, 129, (2020)
104. Soldatos T., McCarthy E.F., Attar S., Carrino J.A., Fayad L.M., Imaging features of chondrosarcoma, Journal of Computer Assisted Tomography, 35, (2011)
105. Speetjens F.M., De Jong Y., Gelderblom H., Bovee J.V., Molecular oncogenesis of chondrosarcoma: Impact for targeted treatment, Current Opinion in Oncology, 28, pp. 314-322, (2016)
106. Stacchiotti S., Sommer J., Building a global consensus approach to chordoma: A position paper from the medical and patient community, The Lancet Oncology, 16, pp. e71-e83, (2015)
107. Stacchiotti S., Gronchi A., Fossati P., Et al., Best practices for the management of local-regional recurrent chordoma: A position paper by the chordoma global consensus group, Annals of Oncology, 28, pp. 1230-1242, (2017)
108. Stark A.M., Mehdorn H.M., Images in clinical medicine. Chondroid clival chordoma, The New England Journal of Medicine, 349, (2003)
109. Steffner R.J., Jang E.S., Staging of bone and soft-tissue sarcomas, The Journal of the American Academy of Orthopaedic Surgeons, 26, pp. e269-e278, (2018)
110. Strauss S.J., Whelan J.S., Current questions in bone sarcomas, Current Opinion in Oncology, 30, pp. 252-259, (2018)
111. Strotman P.K., Reif T.J., Kliethermes S.A., Sandhu J.K., Nystrom L.M., Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the seer database (2001 − 2011), Journal of Surgical Oncology, 116, pp. 252-257, (2017)
112. Subhawong T.K., Winn A., Shemesh S.S., Pretell-Mazzini J., F-18 fdg pet differentiation of benign from malignant chondroid neoplasms: A systematic review of the literature, Skeletal Radiology, 46, pp. 1233-1239, (2017)
113. Behzadi A.H., Raza S.I., Carrino J.A., Et al., Applications of PET/CT and PET/MR imaging in primary bone malignancies, PET Clinics, 13, pp. 623-634, (2018)
114. Thorkildsen J., Taksdal I., Bjerkehagen B., Et al., Chondrosarcoma in norway 1990-2013: An epidemiological and prognostic observational study of a complete national cohort, Acta Oncologica, 58, pp. 273-282, (2019)
115. Tian R., Su M., Tian Y., Et al., Dual-time point PET/CT with f-18 fdg for the differentiation of malignant and benign bone lesions, Skeletal Radiology, 38, pp. 451-458, (2009)
116. Tinkle C.L., Lu J., Han Y., Et al., Curative-intent radiotherapy for pediatric osteosarcoma: The St. Jude experience, Pediatric Blood & Cancer, 66, (2019)
117. Toomey E.C., Schiffman J.D., Lessnick S.L., Recent advances in the molecular pathogenesis of ewing's sarcoma, Oncogene, 29, pp. 4504-4516, (2010)
118. Tsukamoto S., Vanel D., Righi A., Donati D.M., Errani C., Parosteal extra-axial chordoma of the second metacarpal bone: A case report with literature review, Skeletal Radiology, 47, pp. 579-585, (2018)
119. Ueda T., Morioka H., Nishida Y., Et al., Objective tumor response to denosumab in patients with giant cell tumor of bone: A multicenter phase ii trial, Annals of Oncology, 26, pp. 2149-2154, (2015)
120. Ueda T., Kubota K., Shiroma N., Et al., Extra-axial chordoma of the gingiva, Auris Nasus Larynx, 47, pp. 299-304, (2020)
121. Vadi S.K., Mittal B.R., Gorla A.K.R., Et al., ¹⁸F-FDG PET/CT in diagnostic and prognostic evaluation of patients with suspected recurrence of chondrosarcoma, Clinical Nuclear Medicine, 43, pp. 87-93, (2018)
122. Van Oosterwijk J.G., Anninga J.K., Gelderblom H., Cleton-Jansen A.M., Bovee J.V., Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma, Hematology/Oncology Clinics of North America, 27, pp. 1021-1048, (2013)
123. Van Praag Veroniek V.M., Rueten-Budde A.J., Ho V., Et al., Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas, Surgical Oncology, 27, pp. 402-408, (2018)
124. Bergh P., Kindblom L.-G., Gunterberg B., Et al., Prognostic factors in chordoma of the sacrum and mobile spine: A study of 39 patients, Cancer, 9, (2000)
125. Vijayamurugan N., Bakhshi S., Review of management issues in relapsed osteosarcoma, Expert Review of Anticancer Therapy, 14, (2014)
126. Walcott B.P., Nahed B.V., Mohyeldin A., Et al., Chordoma: Current concepts, management, and future directions, The Lancet Oncology, 13, pp. e69-e76, (2012)
127. Wang H., Wan N., Hu Y., Giant cell tumour of bone: A new evaluating system is necessary, International Orthopaedics, 36, pp. 2521-2527, (2012)
128. Whelan J.S.D., Davis L.E., Osteosarcoma, chondrosarcoma, and chordoma, Journal of Clinical Oncology, 36, (2018)
129. Widhe B., Widhe T., Initial symptoms and clinical features in osteosarcoma and ewing sarcoma, The Journal of Bone and Joint Surgery, 82, pp. 667-674, (2000)
130. Wold L.E., Laws E.R., Cranial chordomas in children and young adults, Journal of Neurosurgery, 59, (1983)
131. Worch J., Cyrus J., Goldsby R., Et al., Racial differences in the incidence of mesenchymal tumors associated with ewsr1 translocation, Cancer Epidemiology, Biomarkers & Prevention, 20, pp. 449-453, (2011)
132. Wu M.H., Xiao L.F., Liu H.W., Et al., Pet/ct-guided versus ct-guided percutaneous core biopsies in the diagnosis of bone tumors and tumor-like lesions: Which is the better choice?, Cancer Imaging, 19, (2019)
133. Bertoni F., Bacchini P., Staals E.L., Malignancy in giant cell tumor of bone, Cancer, 97, pp. 2520-2529, (2003)
134. Bielack S., Jurgens H., Jundt G., Et al., Osteosarcoma: The coss experience, Cancer Treatment and Research, 152, pp. 289-308, (2009)
135. Biermann J.S., Adkins D.R., Agulnik M., Et al., Bone cancer, Journal of the National Comprehensive Cancer Network, 11, pp. 688-723, (2013)
136. Bitzer A., McCarthy E.F., Morris C.D., Extra-axial chordoma of the hand, The Journal of Hand Surgery, 42, pp. 933.e1-933.e5, (2017)
137. Bosma S.E., Ayu O., Fiocco M., Gelderblom H., Dijkstra P.D.S., Prognostic factors for survival in ewing sarcoma: A systematic review, Surgical Oncology, 27, pp. 603-610, (2018)
138. Brenner W., Conrad E.U., Eary J.F., Fdg pet imaging for grading and prediction of outcome in chondrosarcoma patients, European Journal of Nuclear Medicine and Molecular Imaging, 31, pp. 189-195, (2004)
139. Briccoli A., Rocca M., Salone M., Et al., Resection of recurrent pulmonary metastases in patients with osteosarcoma, Cancer, 104, pp. 1721-1725, (2005)
140. Byun B.H., Kong C.B., Lim I., Et al., Combination of 18F-FDG PET/CT and diffusion-weighted mr imaging as a predictor of histologic response to neoadjuvant chemotherapy: Preliminary results in osteosarcoma, Journal of Nuclear Medicine, 54, pp. 1053-1059, (2013)
141. Byun B.H., Kong C.B., Lim I., Et al., Comparison of (18)F-FDG PET/CT and (99 m)tc-mdp bone scintigraphy for detection of bone metastasis in osteosarcoma, Skeletal Radiology, 42, pp. 1673-1681, (2013)
142. Callister M.E., Baldwin D.R., Akram A.R., Et al., British thoracic society guidelines for the investigation and management of pulmonary nodules, Thorax, 70, pp. ii1-ii54, (2015)
143. Campanacci D.A., Scoccianti G., Franchi A., Et al., Surgical treatment of central grade 1 chondrosarcoma of the appendicular skeleton, Journal of Orthopaedics and Traumatology, 14, pp. 101-107, (2013)
144. Campbell K.M., Shulman D.S., Grier H.E., Dubois S.G., Role of bone marrow biopsy for staging new patients with ewing sarcoma: A systematic review, Pediatric Blood & Cancer, 68, (2020)
145. Caracciolo J.T., Temple H.T., Letson G.D., Kransdorf M.J., A modified lodwick-madewell grading system for the evaluation of lytic bone lesions, AJR. American Journal of Roentgenology, 207, pp. 150-156, (2016)
146. Casali P.G., Messina A., Stacchiotti S., Et al., Imatinib mesylate in chordoma, Cancer, 101, pp. 2086-2097, (2004)
147. Casali P.G., Bielack S., Abecassis N., Et al., Bone sarcomas: Esmo-paedcan-euracan clinical practice guidelines for diagnosis, treatment and follow-up, Annals of Oncology, 29, pp. iv79-iv95, (2018)
148. Casillas J., Ross J., Keohan M.L., Bleyer A., Malagolowkin M., Ries L.G., Soft tissue sarcomas, Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including Seer Incidence and Survival: 1975-2000, (2006)
149. Chakarun J.C., Forrester D.M., Gottsegen C.J., Patel D.B., White E.A., Matcuk G.R., Giant cell tumor of bone: Review, mimics, and new developments in treatment, Radiographics, 33, (2013)
150. Chang C., Chebib I., Torriani M., Bredella M., Osseous metastases of chordoma: Imaging and clinical findings, Skeletal Radiology, 46, pp. 351-358, (2017)
151. Chen E.L., Yoo C.H., Gutkin P.M., Et al., Outcomes for pediatric patients with osteosarcoma treated with palliative radiotherapy, Pediatric Blood & Cancer, 67, (2020)
152. Chow W.A., Chondrosarcoma: Biology, genetics, and epigenetics, F1000Res, 7, (2018)
153. Chugh R., Tawbi H., Lucas D.R., Et al., Chordoma: The nonsarcoma primary bone tumor, The Oncologist, 12, pp. 1344-1350, (2007)
154. Cistaro A., Durando S., Paze F., Et al., Expansive masses arising from the clivus: The role of FDG-PET/CT in the metabolic assessment of skeletal lesions, Journal of Radiology Case Report, 3, pp. 33-40, (2009)
155. Compton M.L., Cates J.M.M., Evidence-based tumor staging of skeletal chondrosarcoma, The American Journal of Surgical Pathology, 44, (2020)
156. Costelloe C.M., Chuang H.H., Madewell J.E., FDG PET/CT of primary bone tumors, AJR. American Journal of Roentgenology, 202, pp. W521-W531, (2014)
157. Cotterill S.J., Ahrens S., Paulussen M., Et al., Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing's sarcoma study group, Journal of Clinical Oncology, 18, pp. 3108-3114, (2000)
158. Cowan R.W., Singh G., Giant cell tumor of bone: A basic science perspective, Bone, 52, pp. 238-246, (2013)